)
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
Real estate AIF plans to exit two independent floor projects and acquire land parcels in South and Lutyens' Delhi, amid rising luxury housing demand and price appreciation
Luxury real estate mkt holds firm; investors selective about buying
According to transaction documents accessed by Propstack, the company will pay rent for a chargeable area of 145,181 square feet, putting the monthly rent rate at ₹185 per square foot
Infrastructure push, industrial growth and relative affordability are expected to drive residential demand and investor interest across Jewar, Noida and Greater Noida markets
Office leasing in India's top cities rose 15% in Q1 CY26, driven by strong occupier demand and GCC expansion, with flex leasing also gaining a larger share
Drug pricing regulator permits marginal MRP increase for NLEM medicines in line with wholesale price index, offering relief to manufacturers facing higher costs
Online pharmacies, drug wholesalers under scanner; non-compliance may lead penalties, license cancellations
ASK Property Fund has exited Mahagun's Noida project with Rs 650 crore, earning a 21 per cent IRR, as the stalled development sees revival following NCLT relief
Domestic medical device makers seek government support as input costs surge up to 50 per cent amid West Asia disruptions, flagging supply chain stress and rising logistics costs
Somerset Indus has closed its third fund at $288 million, exceeding its target, and plans larger investments across healthcare, medtech, and insurance-linked sectors
CDSCO flagged four drugs as spurious and 194 as not of standard quality in February 2026, including widely used medicines, as part of routine surveillance
Off-patent GLP-1 therapy drives 70-90% price drop with generics flooding in
ATS eyes delivery of project in 18 to 24 months, reset in core NCR luxury market
Drugmaker expects to receive regulatory approval for weightloss sema generic in a few months
As semaglutide goes off patent, doctors warn of misuse by non-obese individuals amid rising demand driven by social media and lower-cost generics
Forced reroutes from Hormuz for ships carrying construction material may raise input costs, delay timelines and push up ultra-luxury housing prices in key cities
Homeland Group and VRC acquire two prime land parcels in Mohali via GMADA auction, planning large mixed-use projects with premium residential and commercial spaces
Firms may shift to doctor outreach, CME programmes and patient support initiatives as CDSCO bars advertising of GLP-1 drugs ahead of semaglutide patent expiry
Union Health Ministry directs research bodies to refrain from informal data sharing and collaborations with foreign agencies without prior approval from competent authorities
Realty company to invest ₹1,000 crore in project featuring 57 floors; construction to be completed by 2031